Population-based study on the prevalence of spirometric obstructive pattern in Porto, Portugal

Respiratory Care

Volumn 56, Issue 5, 2011, Pages 619-625

  Mascarenhas, Joana ^a,b   Falcão, Helena ^a,c   Lourenço, Patrícia ^a,b   Paulo, Cristiana ^a,b   Patacho, Marta ^a,b   Bettencourt, Paulo ^a,b,d   Azevedo, Ana ^a,b,d  

^a University of Porto   (Portugal)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

^c Centro Hospitalar Universitario do Porto   (Portugal)

^d Unidade de Investigação e Desenvolvimento Cardiovascular Do Porto   (Portugal)

Author keywords

OLD; Population; Prevalence; Spirometry

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PORTUGAL; PREVALENCE; SELF REPORT; SEX DIFFERENCE; SMOKING; SPIROMETRY; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; RETROSPECTIVE STUDY;

FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PORTUGAL; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SPIROMETRY;

EID: 79960612709     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.00698     Document Type: Article

References (45)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. http://www.goldcopd.com. Accessed March 9, 2011.
2. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27(2):397-412.
3. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004;364(9434):613-620.
4. Pearson MG, Alderslade R, Allen SC, Apps MCP, Barnes G, Bellamy D, et al; COPD guidelines group of the Standards of Care Committee of the British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52(S5):S1-S28.
5. American Thoracic Society/European Respiratory Society Task Force. Standards for the diagnosis and management of patients with COPD. Version 1.2. New York: American Thoracic Society; 2004. Updated September 8, 2005. http://www.thoracic.org/clinical/copdguidelines. Accessed March 9, 2011.
6. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349(9064):1498-1504.
7. de Marco R, Accordini S, Cerveri I, Corsico A, Sunyer J, Neukirch F, et al; European Community Health Survey Study Group. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004;59(2):120-125.
8. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002;121 (S5):121S-6S.
9. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370(9589):765-773.
10. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003; 123(5):1684-1692.
11. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370(9589):741-750.
12. Menezes AMB, Perez-Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, et al; PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366(9500):1875-1881.
13. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160(11):1683-1689.
14. Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006; 61(12):1043-1047.
15. 1/FVC as a criterion of COPD? Respir Med 2007; 101(6):1097-1105.
16. World Health Organization, Department of Measurement and Health Information. Mortality and burden of diseases for WHO member states in 2002 workbook. http://www.who.int/healthinfo/statistics/bodgbddeathdalyestimates.xls. Accessed March 9, 2011.
17. Ramos E, Lopes C, Barros H. Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. Ann Epidemiol 2004;14(6):437-441.
18. Pi-Sunyer FX, Becker DM, Bouchard C, Carleton RA, Colditz GA, Dietz WH, et al; Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 1998;68(4):899-917.
19. Perillo M, Boschetti PS. Spirolab II user's manual, rev. 2. Medical International Research; 2001.
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardization of spirometry. Eur Respir J 2005;26(2):319-338.
21. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS workshop on lung volume measurements. Official statement of the European Respiratory Society. Eur Respir J 2005;8(3):492-506.
22. Rennard S, Decramer M, Calverley PMA, Pride NB, Soriano JB, Vermeire PA, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002;20(4):799-805.
23. Azevedo A, Bettencourt P, Pimenta J, Friões F, Abreu-Lima C, Hense HW, Barros H. Clinical syndrome suggestive of heart failure is frequently attributable to non-cardiac disorders: population-based study. Eur J Heart Fail 2007;9(4):391-396.
24. Pena VS, Miravitlles M, Gabriel R, Jiménez-Ruiz CA, Villasante C, Masa JF, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicenter epidemiological study. Chest 2000;118(4):981-989.
25. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28(3):523-532.
26. Hansen JG, Pedersen L, Overvad K, Omland O, Jensen HK, Sorensen HT. The prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population based study. COPD 2008; 5(6):347-352.
27. Mannino DM, Buist AS, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007;62(3):237-241.
28. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly neversmokers. Eur Respir J 2002;20(5):1117-1122.
29. 1/FVC ratio below the fifth percentile, not 70%. Chest 2007;131(2):349-355.
30. Lindberg A, Jonsson AC, Ronmark E, Lundgren R, Larsson LG, Lundbäck B. Prevalence of obstructive pulmonary disease according to BTS, ERS, GOLD, and ATS criteria in relation to doctor diagnosis, symptoms, age, gender, and smoking habits Respiration 2005; 72(5):471-479.
31. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003;22(2): 268-273.
32. Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Rutten-van Molken MP. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001;164(4):590-596.
33. Cavelaars AEJM, Kunst AE, Geurts JJM, Crialesi R, Grotvedt L, Helmert U, et al. Educational differences in smoking: international comparison. BMJ 2000;320(7242):1102-1107.
34. Santos AC, Barros H. Smoking patterns in a community sample of Portuguese adults, 1999-2000. Prev Med 2004;38(1):114-119.
35. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med 2004;10(2):98-103.
36. de Torres JP, Campo A, Casanova C, Aguirre-Jaime A, Zulueta J. Gender and chronic obstructive pulmonary disease in high-risk smokers. Respiration 2006;73(3):306-310.
37. Ko FWS, Hui DSC. Outdoor air pollution: impact on chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2009; 15(2):150-157.
38. Liu Y, Lee K, Perez-Padilla R, Hudson NL, Mannino DM. Outdoor and indoor air pollution and COPD-related diseases in high and low-income countries. Int J Tuberc Lung Dis 2008;12(2):115-127.
39. 10 and attenuated age-related decline in lung function. N Engl J Med 2007;357(23):2338-2347.
40. Schikowski T, Sugiri D, Ranft U, Gehring U, Heinrich J, Wichmann HE, Krämer U. Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res 2005; 6:152.
41. CCDRN (Comissão de Coordenção e Desenvolvimento Regional do Norte). Ambiente. Estado da Qualidade do Ar na Região Norte: 2005. http://www.ccr-norte.pt/ambiente/qualiar.php. Accessed March 9, 2011.
42. 10 concentrations in WCE and SEE, 2003, showing the 36th highest daily values at urban background sites superimposed on rural concentrations. EEA-ETC/ ACC Technical Paper; 2007. http://www.eea.europa.eu/data-and-maps/figures/map-of-pm10-concentrations-in-wce-and-see-2003-showing-the-36th-highest-daily-values-at-urban-background-sites-superimposedon-rural-concentrations-maps-constructed-from-measurements-and-model-calculations-eea-etc-acc-technical-paper-2005-2008-1. Accessed March 9, 2011.
43. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005;60(10): 842-847.
44. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow-up study. Thorax 2003;58(5):388-393.
45. Rebuck DA, Hanania NA, D'Urzo AD, Chapman KR. The accuracy of a handheld portable spirometer. Chest 1996;109(1):152-157.